Clinical Trials Logo

Clinical Trial Summary

The first phase of this pilot study will assess changes in quality of life at the end of a 16-week Mymee program in patients with moderate to severe SLE. The second phase will assess changes in healthcare utilization and cost over a one year period after program end.


Clinical Trial Description

Intervention Group The Intervention Group will enter daily tasks into the Mymee app. After the first intake session, the subject will participate in weekly 20-30-minute coaching sessions with the Health Coach. At the second session, the Health Coach will review the symptoms and the free text entered by the subject to determine which dietary and environmental factors will be monitored in the Mymee app.

Each subsequent week, the Health Coach will review and discuss with the subject the food diary and the data entered into the Mymee app during the previous week. Based on this discussion and the subject's medical records, the Health Coach will determine or revise which symptoms will continue to be monitored using the Mymee App.

Control Group The Control Group subjects will receive no training, coaching, or other intervention services from Mymee. The Control Group subjects will complete the same battery of assessments at the same intervals as the Intervention Group subjects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03426384
Study type Interventional
Source Mymee Inc.
Contact
Status Completed
Phase N/A
Start date February 12, 2018
Completion date December 5, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04024306 - Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
Active, not recruiting NCT04018222 - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Completed NCT04527172 - Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
Completed NCT05458531 - Monitoring of Inflammatory Conditions
Completed NCT04970199 - Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus N/A
Recruiting NCT05984316 - Systemic Lupus Erythematosus N/A
Completed NCT03171194 - Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus Phase 1
Recruiting NCT06383104 - Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus. N/A
Not yet recruiting NCT05314881 - NCF Gene & TNFSF4 in SLE Patients N/A
No longer available NCT04907175 - Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)